Forecast: Hepatitis B Immunisation in Indonesia

From 2013 to 2023, Indonesia's Hepatitis B immunization coverage experienced fluctuations. The coverage peaked at 99 in 2013, followed by a decline in the subsequent years, bottoming out at 80.1 in 2021 during the COVID-19 pandemic. Since then, there has been a slight recovery, with coverage standing at 83.5 in 2023. The average year-on-year variation was notably negative, indicating an overall declining trend during this ten-year period.

Forecasted data from 2024 to 2028 shows minimal growth, with the expected coverage stabilizing around 83.7 by 2028. The forecast five-year CAGR also suggests negligible growth at 0.05%, implying that significant improvements in immunization rates are unlikely without policy changes or interventions. Over the last five years, the CAGR has averaged -2.05%, reflecting a period of recovery yet sluggish growth.

Future trends to watch for:

  • Potential impacts of new health policies or government initiatives aiming to boost immunization rates
  • Technological developments and innovations in vaccine delivery systems
  • Effects of public health campaigns and education on immunization practices

Top Countries about Immunology